IN2014MN01552A - - Google Patents
Info
- Publication number
- IN2014MN01552A IN2014MN01552A IN1552MUN2014A IN2014MN01552A IN 2014MN01552 A IN2014MN01552 A IN 2014MN01552A IN 1552MUN2014 A IN1552MUN2014 A IN 1552MUN2014A IN 2014MN01552 A IN2014MN01552 A IN 2014MN01552A
- Authority
- IN
- India
- Prior art keywords
- geranylgeranylacetone
- alone
- mixture
- retinal diseases
- retinal
- Prior art date
Links
- DJAHKBBSJCDSOZ-AJLBTXRUSA-N (5z,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one;(5e,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C/CCC(C)=O.CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O DJAHKBBSJCDSOZ-AJLBTXRUSA-N 0.000 abstract 6
- 229950006156 teprenone Drugs 0.000 abstract 6
- 208000017442 Retinal disease Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000030833 cell death Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000002207 retinal effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012040803 | 2012-02-27 | ||
| PCT/JP2013/054774 WO2013129315A1 (ja) | 2012-02-27 | 2013-02-25 | 網膜疾患の予防、改善、又は治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01552A true IN2014MN01552A (enrdf_load_html_response) | 2015-05-08 |
Family
ID=49082513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1552MUN2014 IN2014MN01552A (enrdf_load_html_response) | 2012-02-27 | 2013-02-25 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20130303625A1 (enrdf_load_html_response) |
| JP (2) | JP5345744B1 (enrdf_load_html_response) |
| CN (1) | CN104136015B (enrdf_load_html_response) |
| IN (1) | IN2014MN01552A (enrdf_load_html_response) |
| TW (1) | TWI566771B (enrdf_load_html_response) |
| WO (1) | WO2013129315A1 (enrdf_load_html_response) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104136015B (zh) | 2012-02-27 | 2016-11-09 | 日本乐敦制药株式会社 | 视网膜疾病的预防、改善或治疗剂 |
| JP5687395B2 (ja) * | 2013-02-19 | 2015-03-18 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療用粘膜適用剤 |
| WO2015029925A1 (ja) * | 2013-08-26 | 2015-03-05 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療剤 |
| JP6628252B2 (ja) * | 2014-02-28 | 2020-01-08 | 国立大学法人京都大学 | 虚血性眼疾患の処置用の医薬組成物 |
| CN108998006B (zh) * | 2018-07-20 | 2021-06-08 | 合肥工业大学 | 一种环境友好的应变响应型荧光超分子材料及其制备方法 |
| CA3116577A1 (en) * | 2018-10-19 | 2020-04-23 | Medicinova, Inc. | Methods of treating ophthalmic disease/disorder or injury with ibudilast |
| CN109470534B (zh) * | 2018-11-12 | 2021-05-25 | 山东骏腾医疗科技有限公司 | 一种病理组织透明脱蜡液及其制备方法 |
| CN109675038A (zh) * | 2019-02-01 | 2019-04-26 | 杭州赫尔斯科技有限公司 | 增强低浓度阿托品类药物安全性和临床疗效的组合物 |
| CN119792302B (zh) * | 2025-03-14 | 2025-06-24 | 山东师范大学 | 前列腺素e2在制备治疗蓝光暴露引发的视网膜损伤的药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06192073A (ja) * | 1992-12-24 | 1994-07-12 | Eisai Co Ltd | 細胞分化誘導剤 |
| JP3560072B2 (ja) | 1994-05-20 | 2004-09-02 | エーザイ株式会社 | 外用基剤 |
| JPH08133967A (ja) * | 1994-11-02 | 1996-05-28 | Eisai Co Ltd | ドライアイ治療剤 |
| JP2000319170A (ja) | 1999-03-05 | 2000-11-21 | Eisai Co Ltd | テプレノン含有点眼剤 |
| US20050009772A1 (en) * | 2003-05-06 | 2005-01-13 | The Regents Of The University Of California | Methods and compositions for the treatment of glaucoma and other retinal diseases |
| CN101600475A (zh) | 2005-07-27 | 2009-12-09 | 佛罗里达大学研究基金会有限公司 | 修正蛋白质错误折叠的小型化合物及其使用 |
| AU2006272586A1 (en) * | 2005-07-27 | 2007-02-01 | University Of Florida Research Foundation, Inc. | Use of heat shock to treat ocular disease |
| WO2012031028A2 (en) * | 2010-09-01 | 2012-03-08 | Coyote Pharmaceuticals, Inc. | Methods for treating neurodegenerative diseases |
| CN104136015B (zh) * | 2012-02-27 | 2016-11-09 | 日本乐敦制药株式会社 | 视网膜疾病的预防、改善或治疗剂 |
-
2013
- 2013-02-25 CN CN201380011312.6A patent/CN104136015B/zh not_active Expired - Fee Related
- 2013-02-25 US US13/775,605 patent/US20130303625A1/en not_active Abandoned
- 2013-02-25 JP JP2013510415A patent/JP5345744B1/ja active Active
- 2013-02-25 WO PCT/JP2013/054774 patent/WO2013129315A1/ja active Application Filing
- 2013-02-25 IN IN1552MUN2014 patent/IN2014MN01552A/en unknown
- 2013-02-25 TW TW102106505A patent/TWI566771B/zh not_active IP Right Cessation
- 2013-07-12 JP JP2013146970A patent/JP2013213049A/ja active Pending
-
2014
- 2014-01-14 US US14/154,688 patent/US9724312B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20130303625A1 (en) | 2013-11-14 |
| TWI566771B (zh) | 2017-01-21 |
| JP5345744B1 (ja) | 2013-11-20 |
| CN104136015B (zh) | 2016-11-09 |
| TW201338771A (zh) | 2013-10-01 |
| US20140128475A1 (en) | 2014-05-08 |
| WO2013129315A1 (ja) | 2013-09-06 |
| CN104136015A (zh) | 2014-11-05 |
| HK1200111A1 (en) | 2015-07-31 |
| JP2013213049A (ja) | 2013-10-17 |
| US9724312B2 (en) | 2017-08-08 |
| JPWO2013129315A1 (ja) | 2015-07-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01552A (enrdf_load_html_response) | ||
| PH12014501718A1 (en) | Novel therapeutic agents | |
| PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
| MX370903B (es) | Composiciones de ácido percarboxílico estables y sus usos. | |
| MY176593A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
| MY185016A (en) | Progenitor cells of mesodermal lineage | |
| MX2015013275A (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevencion de enfermedades o afecciones asociadas con difucion mitocondrial. | |
| MX2013008192A (es) | Inhibidores de bace-2 para tratamiento de transtornos metabolicos. | |
| IN2014DN06104A (enrdf_load_html_response) | ||
| BR112014015342A2 (pt) | células-tronco pluripotentes induzidas de células derivadas do tecido do cordão umbilical humano | |
| PH12014502805A1 (en) | Novel indanesulfamide derivative | |
| TN2013000239A1 (en) | New form of administration of enkephalinase inhibitor | |
| MX359002B (es) | Metodo y composicion para prevenir la interrupcion y agregacion de celulas madre. | |
| MY171048A (en) | Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions | |
| MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| IN2014MN01551A (enrdf_load_html_response) | ||
| PH12015501561A1 (en) | Method of treatment of diseases | |
| PH12013502563A1 (en) | Dha and epa in the reduction of oxidative stress | |
| WO2014005153A3 (en) | Methods for treating mds1-evi1 mediated cancer | |
| PH12015501109A1 (en) | Novel compounds as diacylglycerol acyltransferase inhibitors | |
| NZ612843A (en) | Pheromone composition | |
| MX342186B (es) | Concentrado alimenticio en forma de gel, y proceso para prepararlo. | |
| MX337593B (es) | Gemcabeno y derivados para tratar la pancreatitis. | |
| UA53379U (ru) | Суспензионный крем для лечения воспалительных стоматологических заболеваний | |
| UA59871U (ru) | Способ ликвидации последствий фосфорной аварии и нейтрализации желтого фосфора |